Mode
Home
Research
Clinical Trials Drug Pipeline Weekly Digests
Reference
Conditions Medications
Community
Questions
Text Size
Log in / Sign up
Home › Medications › Olaratumab

Olaratumab

0 published articles · Updated continuously

Clinical Trial Landscape

Clinical Trials of Olaratumab

15 trials tracked of Olaratumab: 1 in phase 3 or 4 and 1 with published results. The most-cited published study has 298 citations.

15Trials tracked
1Phase 3 & 4
0Recruiting
1With published results
Phase distribution
Phase 3 1 Phase 2 7 Phase 1 7
  1. Phase 3 A Study of Doxorubicin Plus Olaratumab (LY3012207) in Participants With Advanced or Metastatic Soft Tissue Sarcoma Completed · 298 cited
  2. Phase 2 A Study of Olaratumab (IMC-3G3) in Prostate Cancer Completed
  3. Phase 2 A Study of Nab-Paclitaxel and Gemcitabine With or Without Olaratumab (LY3012207) in Participants With Metastatic Pancreatic Cancer Completed
  4. Phase 2 Ramucirumab or Anti-PDGFR Alpha Monoclonal Antibody IMC-3G3 in Treating Patients With Recurrent Glioblastoma Multiforme Completed
  5. Phase 2 A Study of Liposomal Doxorubicin With or Without Olaratumab (IMC-3G3) in Platinum-Refractory or Resistant Advanced Ovarian Cancer Completed
  6. Phase 2 A Study of Olaratumab in Soft Tissue Sarcoma Completed
Show 9 more trials
  1. Phase 2 A Study of Olaratumab (LY3012207) in Participants With Advanced Soft Tissue Sarcoma Completed
  2. Phase 2 A Study of Paclitaxel/Carboplatin With or Without Olaratumab (IMC-3G3) in Previously Untreated Locally Advanced or Metastatic Non-Small Cell Lung Cancer (NSCLC) Completed
  3. Phase 1 A Study of Olaratumab in Japanese Participants With Advanced Cancer Completed
  4. Phase 1 A Study of Olaratumab (LY3012207), Doxorubicin, and Ifosfamide in Participants With Advanced or Metastatic Soft Tissue Sarcoma Completed
  5. Phase 1 A Study of Olaratumab and Doxorubicin in Participants With Advanced Soft Tissue Sarcoma Completed
  6. Phase 1 A Study of Olaratumab Alone and in Combination With Standard Chemotherapies in Children With Cancer Completed
  7. Phase 1 A Study of Olaratumab (LY3012207) in Participants With Soft Tissue Sarcoma Completed
  8. Phase 1 Study of the Safety and Pharmacokinetics of Olaratumab (IMC-3G3) in Japanese Participants With Solid Tumors Completed
  9. Phase 1 A Study of Olaratumab (LY3012207) Plus Pembrolizumab in Participants With Advanced or Metastatic Soft Tissue Sarcoma Completed

Showing the 15 most-cited and recently-updated of 15 trials. Browse the full registry →

Trial data sourced from ClinicalTrials.gov. Counts describe the research landscape and are not a treatment recommendation. Informational only — not medical advice.

HCP Mode — summaries include clinical detail, trial data, and statistical outcomes.
Patient Mode — summaries use plain language, avoiding clinical jargon.
No published articles yet for this medication. Check back soon.